Cramer says this newly spun-off stock that helps our food grow is a buy. Here's why
The top performer of the three companies created when the DowDuplant experiment unwound in 2019 has now split itself in two.
TL;DR
- Jim Cramer prefers Vylor, a new standalone company focused on advanced seed and genetics, over Corteva.
- Vylor operates in a high-tech, high-margin business with a strong research pipeline and licensing potential.
- Corteva, now focused on crop protection, is considered a more commodity-based and 'stagnant' business by Cramer.
- Vylor is expected to conduct significant share repurchases from 2027-2029 and offers a modest dividend.
- Despite a premium valuation, Cramer believes Vylor deserves its price, though it leaves less room for error.